Call TODAY and tell your Senator to vote NO on BCRA!
This activity will cover the three major steps in normal hemostasis and the basics of treatment and management of patients with hemophilia.
FDA approves the Biologics License Application (BLA) for REBINYN®
New therapy failed to show significant efficacy in a phase I/II clinical study.
A wider perspective on the "burden" hemophilia patients place on health plans.
The Nationwide Children’s Hospital Pediatric Hematology Division along with its affiliated institution, The Ohio State University College of Medicine, are jointly hosting an upcoming educational tr
The Partners in Bleeding Disorders Education Program recently relaunched “A School Nurses Guide to Bleeding Disorders: von Willebrand Disease.”
NHF's update on the CBO scoring of the AHCA; President Trump's proposed budget, and how it will all affect you.
NHF hosted a festive benefit gala, the Red Tie Soiree, on Thursday, May 18, 2017 in New York City.
sCJD arises in patients with no known risk factors for the disease.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car